Article Details

AstraZeneca: CALLA Phase III Trial for Imfinzi failed to achieve statistical significance

Retrieved on: 2022-03-24 08:45:20

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca: CALLA Phase III Trial for Imfinzi failed to achieve statistical significance. View article details on hiswai:

Excerpt

AstraZeneca did not achieve statistical significance in its CALLA Phase III study for locally advanced cervical cancer using Imfinzi with ...

Article found on: ukinvestormagazine.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up